Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,005 public trials 1,217 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

NCT00085189

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Extraocular Extension Melanoma, +31 more
Locations: University of Southern California Los Angeles, California, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

NCT00334776

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

NCT00669019

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas

NCT00274755

Conditions: Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +16 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

NCT00281957

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

East Bay Radiation Oncology Center Castro Valley, California, United States

Eden Hospital Medical Center Castro Valley, California, United States

Valley Medical Oncology Consultants-Castro Valley Castro Valley, California, United States

View all 173 locations

View Trial Details

Completed

Tailored Intervention for Melanoma Patient's Families

NCT00816374

Conditions: Melanoma, Melanoma, Cutaneous Malignant, Neoplasms, +10 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma

NCT00436605

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: Yale University New Haven, Connecticut, United States

Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme

NCT00641706

Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

The Medical Center of Aurora Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose-Saint Francis Healthcare Colorado Springs, Colorado, United States

View all 214 locations

View Trial Details

Completed

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

NCT00492089

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma, +126 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain

NCT01266967

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +16 more
Locations: GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site San Francisco, California, United States

GSK Investigational Site San Francisco, California, United States

GSK Investigational Site Ann Arbor, Michigan, United States

View all 24 locations

View Trial Details